We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Glycemic Response Testing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01536860
Recruitment Status : Completed
First Posted : February 22, 2012
Results First Posted : November 27, 2013
Last Update Posted : November 27, 2013
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to assess whether added food ingredient(s) affect glycemic responses to a liquid meal tolerance test (LMTT).

Condition or disease Intervention/treatment
Glycemic Index Glycemic Response Other: Dietary Intervention

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Glycaemic Response Testing
Study Start Date : February 2012
Primary Completion Date : March 2012
Study Completion Date : March 2012
Arms and Interventions

Arm Intervention/treatment
Placebo Comparator: Control Test Drink
control drink
Other: Dietary Intervention
300 ml of liquid food product
Experimental: Experimental Test Drink 1
control drink containing ingredient 1
Other: Dietary Intervention
300 ml of liquid food product
Experimental: Experimental Test Drink 2
Control drink containing ingredient 2
Other: Dietary Intervention
300 ml of liquid food product


Outcome Measures

Primary Outcome Measures :
  1. Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products [ Time Frame: 0-120 minutes ]
    The individual glucose measurements were collected at baseline (prior to consumption of each test food product and 15, 30, 45, 60, 90 and 120 minutes following the initiation of consumption of each test food product. The positive incremental area under the time-concentration curve (iAUC) was then calculated for the entire 120 minutes after consumption of each test food product. The results show the differential treatment-related effect on the time-concentration curve (iAUC) for the entire 120 minutes post consumption of each test food product.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or female (not less than 40% males or females
  • Non-smoker
  • Aged 18 to 55 years
  • Have a body mass index between 18.5 to 29.99 kg/m2
  • Healthy, non-diabetic, no gastric bypass surgery
  • Not allergic to mustard, dairy or soy
  • Having a fasting plasma glucose (finger stick) <100 mg/dl (<5.5 mmol/L)
  • Willing and able to provide written informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01536860


Locations
United Kingdom
Reading Scientific Services Limited (RSSL)
Reading, Berkshire, United Kingdom, RG6 6BZ
Sponsors and Collaborators
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Investigators
Principal Investigator: Valerie Hart, SCS, Dip, MICR RSSL
More Information

Responsible Party: Mondelēz International, Inc.
ClinicalTrials.gov Identifier: NCT01536860     History of Changes
Other Study ID Numbers: P12-00794
First Posted: February 22, 2012    Key Record Dates
Results First Posted: November 27, 2013
Last Update Posted: November 27, 2013
Last Verified: November 2013